Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06614400
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-28
Brief Title:
The RETRAIN Trial Phase 1
Sponsor:
None
Organization:
None
Study Overview
Official Title:
MonitoRing the Effect of TRAnscutaneous Functional ElectrIcal Stimulation of the Common Peroneal Nerve on Cerebral Haemodynamics in Patients with Ischaemic Strokes a Single Centre Prospective Study Phase 1
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RETRAIN
Brief Summary:
The primary objective is to investigate in stroke patients the impact of geko NMES treatment when used as standard of care for VTE prevention on brain haemodynamics at different stimulation levels and in three different postural positions supine semi-supine 45 seated and seated The aim is to identify the optimal stimulation level and postural position for the maximum response NMES versus no NMES with regard to relative total haemoglobin concentration ie the sum of relative deoxyhaemoglobin and oxyhaemoglobin concentrations using fNIRS and EEG
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None